Growth failure due to inhaled corticosteroid therapy.
Kumah-Crystal
Yaa
Y
Vanderbilt Children’s Hospital, 2200 Children’s Way, Nashville, TN 37232-9760, USA. yaa.kumah@vanderbilt.edu
Lomenick
Jefferson P
JP
D000280:Administration, Inhalation; D000730:Androstadienes / Q000008:administration & dosage / Q000009:adverse effects*; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001249:Asthma / Q000188:drug therapy*; D001827:Body Height / Q000187:drug effects*; D003345:Corticosterone / Q000008:administration & dosage / Q000009:adverse effects*; D000068298:Fluticasone; D005938:Glucocorticoids / Q000009:adverse effects*; D006130:Growth Disorders / Q000175:diagnosis / Q000209:etiology*; D006801:Humans; D007223:Infant; D008297:Male
D000730:Androstadienes; D018927:Anti-Asthmatic Agents; D005938:Glucocorticoids; D000068298:Fluticasone; D003345:Corticosterone